Riverhead Capital Management’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $86K | Hold |
1,517
| – | – | ﹤0.01% | 1363 |
|
|
2019
Q2 | $84K | Hold |
1,517
| – | – | ﹤0.01% | 1380 |
|
|
2019
Q1 | $77K | Hold |
1,517
| – | – | ﹤0.01% | 1379 |
|
|
2018
Q4 | $61K | Buy |
1,517
+200
| +15% | +$8.04K | ﹤0.01% | 1392 |
|
|
2018
Q3 | $91K | Buy |
1,317
+100
| +8% | +$6.91K | ﹤0.01% | 1414 |
|
|
2018
Q2 | $92K | Hold |
1,217
| – | – | ﹤0.01% | 1361 |
|
|
2018
Q1 | $64K | Buy |
1,217
+200
| +20% | +$10.5K | ﹤0.01% | 1431 |
|
|
2017
Q4 | $54K | Buy |
1,017
+200
| +24% | +$10.6K | ﹤0.01% | 1465 |
|
|
2017
Q3 | $49K | Buy |
817
+251
| +44% | +$15.1K | ﹤0.01% | 1449 |
|
|
2017
Q2 | $45K | Buy |
566
+266
| +89% | +$21.1K | ﹤0.01% | 1435 |
|
|
2017
Q1 | $25K | Buy |
+300
| New | +$25K | ﹤0.01% | 1439 |
|